Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in TaxesChange in TaxesChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Amortization of Goodwill (2021 - 2024)

Trinity Biotech's Amortization of Goodwill history spans 4 years, with the latest figure at $962000.0 for Q4 2024.

  • On a quarterly basis, Amortization of Goodwill rose 231.72% to $962000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $4.3 million, a 2.05% increase, with the full-year FY2024 number at $1.4 million, down 87.32% from a year prior.
  • Amortization of Goodwill hit $962000.0 in Q4 2024 for Trinity Biotech, up from $290000.0 in the prior quarter.
  • Over the last five years, Amortization of Goodwill for TRIB hit a ceiling of $3.0 million in Q4 2022 and a floor of $519.0 in Q2 2022.
  • Historically, Amortization of Goodwill has averaged $861097.8 across 4 years, with a median of $583000.0 in 2021.
  • The widest YoY moves for Amortization of Goodwill: up 246.12% in 2022, down 91.45% in 2022.
  • Tracing TRIB's Amortization of Goodwill over 4 years: stood at $876000.0 in 2021, then skyrocketed by 246.12% to $3.0 million in 2022, then crashed by 90.44% to $290000.0 in 2023, then surged by 231.72% to $962000.0 in 2024.
  • Business Quant data shows Amortization of Goodwill for TRIB at $962000.0 in Q4 2024, $290000.0 in Q4 2023, and $3.0 million in Q4 2022.